Your session is about to expire
← Back to Search
Cognitive Processing Therapy for PTSD (CF-CPT Trial)
N/A
Waitlist Available
Led By Tara Ellen Galovski, PhD MA BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Serious drug or alcohol abuse that requires immediate medical attention (e.g. inpatient care)
Current mania
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered at baseline, mid-treatment (after session 6), two weeks following treatment (post-treatment), and at the 3-month follow-up interval.
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the efficacy of cognitive processing therapy (CPT) to cognitive processing therapy with case formulation (CF-CPT) in treating PTSD among US Veterans.
Who is the study for?
This trial is for US Veterans with PTSD who are not currently experiencing severe mental health issues like active suicidal thoughts, homicidal tendencies, mania, psychosis, or serious substance abuse needing immediate attention. They shouldn't be in another trauma-focused therapy but can continue stable psychiatric medications.
What is being tested?
The study compares two methods of treating PTSD: standard Cognitive Processing Therapy (CPT) and a personalized version that includes Case Formulation (CF-CPT). It aims to see if CF-CPT improves psychosocial functioning and quality of life more than CPT alone over treatment and follow-up periods.
What are the potential side effects?
While specific side effects are not listed for these therapies, psychological interventions may sometimes cause temporary increases in distress due to discussing traumatic events or changes in mood and behavior as individuals work through their experiences.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not need immediate medical help for drug or alcohol use.
Select...
I am currently experiencing a manic episode.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ administered at baseline, mid-treatment (after session 6), two weeks following treatment (post-treatment), and at the 3-month follow-up interval.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered at baseline, mid-treatment (after session 6), two weeks following treatment (post-treatment), and at the 3-month follow-up interval.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinician-Administered PTSD Scale-5 (CAPS) (assessing change over time)
Inventory of Psychosocial Functioning (assessing change over time)
Secondary study objectives
Beck Suicidal Ideation Scale (assessing change over time)
Brief Addiction Monitor (assessing change over time)
DSM-5 Cross-cutting symptom measure (CCSM) (assessing change over time)
+18 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Case Formulation plus Cognitive Processing TherapyExperimental Treatment1 Intervention
The CF approach alters the CPT protocol in two ways: expanding the protocol to intentionally and systematically address impairment in functioning, and enhancing the providers' latitude to navigate challenges to optimal therapy outcomes (COTOS). CF-CPT begins with a formal CF assessment session; elements of CF are then integrated throughout CPT. CF modifications to the original CPT protocol occur in each session by intentionally attending to cognitions that are impeding the patient's functional recovery. The second modification includes enhancing the provider's latitude to diverge from the protocol when clinically wise. CF-CPT provides guidance around the identification, monitoring and management of COTOs, and, importantly, the expedient return to the CPT protocol with continued attention to COTOs.
Group II: Cognitive Processing TherapyActive Control1 Intervention
CPT is a brief therapy for PTSD predominantly based on cognitive theory. Traditionally delivered over 12 one-hour sessions weekly or twice weekly, CPT is now variable length depending on patient's recovery from PTSD. CPT is delivered in three phases: education, processing, and challenging and focuses on challenging beliefs and assumptions related to the trauma, oneself, and the world. Changing dysfunctional beliefs alters negative emotions emanating from those beliefs.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,633 Total Patients Enrolled
Tara Ellen Galovski, PhD MA BSPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Shannon M. Kehle-Forbes, PhDPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
2 Previous Clinical Trials
102 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not need immediate medical help for drug or alcohol use.My psychiatric medication dose has been stable for at least one month.I am currently experiencing a manic episode.You have PTSD and are a veteran.
Research Study Groups:
This trial has the following groups:- Group 1: Case Formulation plus Cognitive Processing Therapy
- Group 2: Cognitive Processing Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger